US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biotechnology Market Research Reports & Industry Analysis

The biotechnology industry encompasses the spectrum of life science-based research companies developing products and services for a wide variety of industries and applications. The industry holds the promise of transformative technologies from agriculture to materials science to environmental science to medicine.
In agriculture, biotech products enhance crop yield, advance the nutritional value and quality of crops and livestock, and improve the efficacy and safety of pesticides. In material science, biotechnology is adding to advances in polymer science and the coatings industry. In environmental science, biotech has contributed innovative solutions to environmental clean-up and waste management.

The biggest direct impact of biotechnology, and the biggest market for its products, is in medicine and healthcare. The biotechnology industry is, in many ways, becoming the research and development engine of the pharmaceutical industry. The tools and techniques of genetic analysis and manipulation are at the heart of the drug discovery process, and many of the largest biotech firms have been transformed over the past decade into pharmaceutical and biopharmaceutical giants.

The biotechnology category covers the companies, technologies, tools, and applications of the advanced life science sector. Included are reports on research methods and equipment such as liquid chromatography, mass spectroscopy, genetic sequencing, gene expression, etc. There are also reports on the business of biotechnology, mergers & acquisitions, and funding. Insofar as the sector intersects with the pharmaceutical industry, there are also reports on product pipelines, strategies for drug development and manufacturing such as biogenerics, biosimilars and biomanufacturing. Reports cover so-called green- and white-biotech sectors as well.

RSS Feeds

Biotechnology Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies)
9/4/2014 | published by: Kalorama Information
... proteins. This includes the study of which proteins are expressed, when and where they are expressed, structure of proteins, roles of proteins, and interactions of proteins. Proteomics is a large field that has focused on ...  |  read more...
USD 4,200
Biopharmaceutical and Vaccine Production Markets
8/29/2014 | published by: Kalorama Information
... stages of clinical drug testing for new biopharmaceuticals, as manufacturers decide when and how to risk production capital to upscale while anticipating FDA or EMA approval. During the past five years, estimates for biopharmaceuticals have ...  |  read more...
USD 3,995
Albany Molecular Research, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Albany Molecular Research, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and ...  |  read more...
USD 350
PolyTherics Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' PolyTherics Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions ...  |  read more...
USD 350
Sartorius Stedim Biotech S.A. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Sartorius Stedim Biotech S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and ...  |  read more...
USD 350
AmpliPhi Biosciences Corporation (formerly Targeted Genetics Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' AmpliPhi Biosciences Corporation (formerly Targeted Genetics Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital ...  |  read more...
USD 350
Five Prime Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Five Prime Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and ...  |  read more...
USD 350
Five Prime Therapeutics, Inc. - Product Pipeline Review - 2014
9/22/2014 | published by: Global Markets Direct
... research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Five Prime Therapeutics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action ...  |  read more...
USD 1,500
RTI Biologics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' RTI Biologics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
Agenus, Inc. (formerly Antigenics, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Agenus, Inc. (formerly Antigenics, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership ...  |  read more...
USD 350
Complete Genomics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Complete Genomics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
BioMarker Strategies, LLC - Product Pipeline Analysis, 2014 Update
9/18/2014 | published by: GlobalData
... next generation predictive tests - known as PathMap profiles - to guide targeted drug therapy selection for individual cancer patients. BioMarker Strategies is developing a pipeline of unique ex vivo biomarker tests to inform targeted ...  |  read more...
USD 750
Biosceptre International Limited - Product Pipeline Analysis, 2014 Update
9/18/2014 | published by: GlobalData
... cancer. Biosceptre’s diagnostic products are used for the detection of various cancer tissues, and treatment of various cancers in humans and other mammals. The company has a series of product development programmes including polyclonal antibody, ...  |  read more...
USD 750
Cavadis B.V. - Product Pipeline Analysis, 2014 Update
9/18/2014 | published by: GlobalData
... of development. Cavadis’s product CAV?RISK ASSAYS is used for cardiovascular indications, and CAV?RISK C?D is developed for coronary artery disease (CAD). The company’s products are developed for cardiovascular indications, including stroke, myocardial infarction (MI), and ...  |  read more...
USD 750
Ceres Nanosciences, Inc. - Product Pipeline Analysis, 2014 Update
9/18/2014 | published by: GlobalData
... development and Nanotrap lyme antigen test. Ceres Nanosciences’ Nanotrap particles are a protein enrichment toolset that can be integrated seamlessly into any existing downstream measurement and analysis process. The company’s Nanotrap High sensitivity lyme antigen ...  |  read more...
USD 750
Nuclea Biotechnologies Inc. - Product Pipeline Analysis, 2014 Update
9/18/2014 | published by: GlobalData
... colon, stomach, leukemia, lung and prostate. Nuclea utilizes its proprietary DecisionDx platform in the development of in vitro companion diagnostics for use in therapeutic and medical imaging applications. It conducts research on novel molecular oncology ...  |  read more...
USD 750
OncoSec Medical Inc. (ONCS) - Product Pipeline Analysis, 2014 Update
9/18/2014 | published by: GlobalData
... two kinds of tests to eradicate various kinds of cancers such as ImmunoPulse and NeoPulse. OncoSec’S ImmunoPulse is used to treat metastatic cancers. The company’s NeoPulse is used to treat primary and recurrent cancers that ...  |  read more...
USD 750
Panacea Biotec Limited (PANACEABIO) - Financial and Strategic SWOT Analysis Review
9/15/2014 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Celera Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Celera Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions ...  |  read more...
USD 350
WaferGen Bio-systems, Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' WaferGen Bio-systems, Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
Genetic Technologies Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Genetic Technologies Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
Lonza Group, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Lonza Group, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' International Stem Cell Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and ...  |  read more...
USD 350
Oxygen Biotherapeutics, Inc. (formerly Synthetic Blood International, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Oxygen Biotherapeutics, Inc. (formerly Synthetic Blood International, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture ...  |  read more...
USD 350
Bayer MaterialScience AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Bayer MaterialScience AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
< prev 1    3  4  5  6  7  8  9  10